Biofactura Granted New US and European Patents for it ' s...

BioFactura’s Multiplex Selection Patent Enhances the Commercial Production of our Biosimilar and Biodefense Assets(PRWeb September 29, 2020)Read the full story at https://www.prweb.com/releases/biofactura_granted_new_us_and_european_patents_for_it_s_stablefast_biomanufacturing_platform/prweb17423125.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals